Bildkälla: Stockfoto

Coegin Pharma: New development agreement and INCI name - Redeye

Redeye leaves a note following Coegin’s recent announcements of a signed Joint Development Agreement (JDA) with an established cosmetics company and a newly granted commercial ingredient brand name for its hair growth products series.

Redeye leaves a note following Coegin’s recent announcements of a signed Joint Development Agreement (JDA) with an established cosmetics company and a newly granted commercial ingredient brand name for its hair growth products series.
Börsvärldens nyhetsbrev
ANNONSER